BIOTRON - Primed to MOVE!
Watching BIOTRON closely. 2 Scenarios:
1. Break of internal trend within the symmetrical triangle will see us return to the .065-.080 region (AREA OF INTEREST).
-We've had 2 bounces on the .382 Fib region creating a double top @ .115 Equilibrium
-Break of internal uptrend trendline.
-Currently broken the center band of bollinger bands.
-We've also had a death cross on MACD and is starting to spread.
-Waiting on break of support at .088
2. If POSITIVE results are announced shortly for any of BIOTRONS Projects/Programs (Anti Viral Drug Program, HIV Program, HBV Program) We should see a break out of Symmetrical Triangle.
-Break of downtrend possible.
-Retest of .011 Equilibrium VERY possible.
-New Market Structure will form with Higher LOW & Higher HIGH.
-Volume will be brought back into the market.
-My next target would be major resistance at .014
A very interesting company with real world prospects. I have been following them since the earlier in the year, with Phase 2 HIV-1 Clinical Trials being successful, HBV Pre-Clinical Trials and work on Anti Viral Drug Development with a keen interest on Covid-19.
These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
1. Break of internal trend within the symmetrical triangle will see us return to the .065-.080 region (AREA OF INTEREST).
-We've had 2 bounces on the .382 Fib region creating a double top @ .115 Equilibrium
-Break of internal uptrend trendline.
-Currently broken the center band of bollinger bands.
-We've also had a death cross on MACD and is starting to spread.
-Waiting on break of support at .088
2. If POSITIVE results are announced shortly for any of BIOTRONS Projects/Programs (Anti Viral Drug Program, HIV Program, HBV Program) We should see a break out of Symmetrical Triangle.
-Break of downtrend possible.
-Retest of .011 Equilibrium VERY possible.
-New Market Structure will form with Higher LOW & Higher HIGH.
-Volume will be brought back into the market.
-My next target would be major resistance at .014
A very interesting company with real world prospects. I have been following them since the earlier in the year, with Phase 2 HIV-1 Clinical Trials being successful, HBV Pre-Clinical Trials and work on Anti Viral Drug Development with a keen interest on Covid-19.
These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.